Pfizer Ltd.
BSE: 500680 | Sector: Health care |
NSE: PFIZER | ISIN Code: INE182A01018 |
BSE 10:27 | 31 Jan | 3879.45 |
-69.25 (-1.75%) |
OPEN
3922.20 |
HIGH
3968.85 |
LOW
3859.05 |
NSE 10:19 | 31 Jan | 3873.80 |
-72.00 (-1.82%) |
OPEN
3940.00 |
HIGH
3953.95 |
LOW
3856.05 |
OPEN | 3922.20 |
PREVIOUS CLOSE | 3948.70 |
VOLUME | 556 |
52-Week high | 4800.00 |
52-Week low | 3859.05 |
P/E | 33.67 |
Mkt Cap.(Rs cr) | 17,748 |
Buy Price | 3871.95 |
Buy Qty | 2.00 |
Sell Price | 3879.45 |
Sell Qty | 1.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Pfizer Ltd. (PFIZER) - Yearly Result
Particulars (![]() |
Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 |
Net Sales/Income From Operations | 2610.99 | 2238.55 | 2151.65 | 2081.50 | 1968.51 |
Other Income | 62.65 | 81.12 | 184.02 | 167.39 | 114.29 |
Total Income | 2673.64 | 2319.67 | 2335.67 | 2248.89 | 2082.80 |
Total Expenditure | 1775.26 | 1526.43 | 1579.09 | 1516.30 | 1468.22 |
Operating Profit | 898.38 | 793.24 | 756.58 | 732.59 | 614.58 |
Interest | 10.49 | 15.11 | 10.85 | 1.29 | 0.42 |
Gross Profit | 887.89 | 778.13 | 745.73 | 731.30 | 614.16 |
Depreciation | 115.00 | 109.41 | 103.24 | 71.39 | 66.25 |
PBT | 772.89 | 668.72 | 642.49 | 659.91 | 547.91 |
Tax | 196.26 | 183.63 | 133.20 | 243.77 | 194.49 |
Net Profit/(Loss) | 612.56 | 497.61 | 509.13 | 429.05 | 360.07 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 612.56 | 497.61 | 509.13 | 429.05 | 360.07 |
Equity Share Capital | 45.75 | 45.75 | 45.75 | 45.75 | 45.75 |
Reserves Excluding Revaluation Reserves | 2818.66 | 2347.29 | 3349.74 | 2965.59 | 2637.45 |
EPS | |||||
Basic EPS | 133.89 | 108.77 | 111.28 | 93.78 | 78.70 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Pfizer:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices